benazepril therapy vs placebo: primary-end-point events in group 1 and group 2
DESCRIPTION
Benazepril therapy vs placebo: Primary-end-point events in group 1 and group 2. Hou FF et al. N Engl J Med 2006; 354:131-140. - PowerPoint PPT PresentationTRANSCRIPT
Benazepril therapy vs placebo: Primary-end-point events in group 1 and group 2
Hou FF et al. N Engl J Med 2006; 354:131-140.
Group 1 Group 2
End point Benazepril Benazepril Placebo
Primary end point (%) 22 (22) 44 (41)* 65 (60)†
*p=0.003 vs benazepril patients in group 1†p=0.004 vs benazepril patients in group 2